Clinical trial
Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis (The MAGMA STUDY)
NCT01276678 is registered in ClinicalTrials.gov with LifeBridge Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis (The MAGMA STUDY)
- Lead sponsor
- LifeBridge Health
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2010
- Completion date
- December 31, 2014
- Enrollment
- 1,300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.